Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: COMPLAINANTS’ OMNIBUS RESPONSE TO RESPONDENTS’ HIGH PRIORITY
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Because of all the secrecy it's tough to even guess.

Simplistically, let's say Otterson/Agility gets 30% off the top for his Contingency risk.

That would leave $35M.

Does TPL still get 15% off the top, i.e. 15% of $50M? If so that's another $7.5M

So that leaves $27.5 to PDS of which PTSC should get $13.75M plus any recuperation of excess funding of PDS by PTSC.

So that's about 7c a share (say $28M on 400M shares and 28/400 = 0.07).

DON'T QUESTION MY NUMBERS!!
COME UP WITH YOUR OWN APPROACH AND LET'S TAKE AN AVERAGE!!

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply